163 related articles for article (PubMed ID: 32204733)
1. Circulating tumour cell liquid biopsy in selecting therapy for recurrent cutaneous melanoma with locoregional pelvic metastases: a pilot study.
Guadagni S; Fiorentini G; Papasotiriou I; Apostolou P; Masedu F; Sarti D; Farina AR; Mackay AR; Clementi M
BMC Res Notes; 2020 Mar; 13(1):176. PubMed ID: 32204733
[TBL] [Abstract][Full Text] [Related]
2. A Pilot Study of the Predictive Potential of Chemosensitivity and Gene Expression Assays Using Circulating Tumour Cells from Patients with Recurrent Ovarian Cancer.
Guadagni S; Clementi M; Masedu F; Fiorentini G; Sarti D; Deraco M; Kusamura S; Papasotiriou I; Apostolou P; Aigner KR; Zavattieri G; Farina AR; Vizzielli G; Scambia G; Mackay AR
Int J Mol Sci; 2020 Jul; 21(13):. PubMed ID: 32646060
[TBL] [Abstract][Full Text] [Related]
3. A Prospective Study of Intraarterial Infusion Chemotherapy in Advanced Wild-Type BRAF Melanoma Patients.
Guadagni S; Zoras O; Fiorentini G; Masedu F; Lasithiotakis K; Sarti D; Farina AR; Mackay AR; Clementi M
J Surg Res; 2021 Dec; 268():737-747. PubMed ID: 34253376
[TBL] [Abstract][Full Text] [Related]
4. Circulating tumour cell gene expression and chemosensitivity analyses: predictive accuracy for response to multidisciplinary treatment of patients with unresectable refractory recurrent rectal cancer or unresectable refractory colorectal cancer liver metastases.
Guadagni S; Masedu F; Fiorentini G; Sarti D; Fiorentini C; Guadagni V; Apostolou P; Papasotiriou I; Parsonidis P; Valenti M; Ricevuto E; Bruera G; Farina AR; Mackay AR; Clementi M
BMC Cancer; 2022 Jun; 22(1):660. PubMed ID: 35710393
[TBL] [Abstract][Full Text] [Related]
5. Does Locoregional Chemotherapy Still Matter in the Treatment of Advanced Pelvic Melanoma?
Guadagni S; Fiorentini G; Clementi M; Palumbo G; Palumbo P; Chiominto A; Baldoni S; Masedu F; Valenti M; Tommaso AD; Fabi B; Aliberti C; Sarti D; Guadagni V; Pellegrini C
Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29120401
[TBL] [Abstract][Full Text] [Related]
6. MGMT methylation correlates with melphalan pelvic perfusion survival in stage III melanoma patients: a pilot study.
Guadagni S; Fiorentini G; Clementi M; Palumbo G; Masedu F; Deraco M; De Manzoni G; Chiominto A; Valenti M; Pellegrini C
Melanoma Res; 2017 Oct; 27(5):439-447. PubMed ID: 28486243
[TBL] [Abstract][Full Text] [Related]
7. Melphalan hypoxic perfusion with hemofiltration for melanoma locoregional metastases in the pelvis.
Guadagni S; Fiorentini G; Clementi M; Palumbo G; Chiominto A; Cappelli S; Masedu F; Valenti M
J Surg Res; 2017 Jul; 215():114-124. PubMed ID: 28688635
[TBL] [Abstract][Full Text] [Related]
8. Surgical versus percutaneous isolated pelvic perfusion (IPP) for advanced melanoma: comparison in terms of melphalan pharmacokinetic pelvic bio-availability.
Guadagni S; Palumbo G; Fiorentini G; Clementi M; Marsili L; Giordano AV; Masedu F; Valenti M
BMC Res Notes; 2017 Aug; 10(1):411. PubMed ID: 28810925
[TBL] [Abstract][Full Text] [Related]
9. Precision oncotherapy based on liquid biopsies in multidisciplinary treatment of unresectable recurrent rectal cancer: a retrospective cohort study.
Guadagni S; Fiorentini G; De Simone M; Masedu F; Zoras O; Mackay AR; Sarti D; Papasotiriou I; Apostolou P; Catarci M; Clementi M; Ricevuto E; Bruera G
J Cancer Res Clin Oncol; 2020 Jan; 146(1):205-219. PubMed ID: 31620896
[TBL] [Abstract][Full Text] [Related]
10. Usefulness of monitoring circulating tumor cells as a therapeutic biomarker in melanoma with BRAF mutation.
Kiniwa Y; Nakamura K; Mikoshiba A; Ashida A; Akiyama Y; Morimoto A; Okuyama R
BMC Cancer; 2021 Mar; 21(1):287. PubMed ID: 33731038
[TBL] [Abstract][Full Text] [Related]
11. Locoregional cutaneous metastases of malignant melanoma and their management.
Wolf IH; Richtig E; Kopera D; Kerl H
Dermatol Surg; 2004 Feb; 30(2 Pt 2):244-7. PubMed ID: 14871216
[TBL] [Abstract][Full Text] [Related]
12. Association between circulating tumor cells and prognosis in patients with stage III melanoma with sentinel lymph node metastasis in a phase III international multicenter trial.
Hoshimoto S; Shingai T; Morton DL; Kuo C; Faries MB; Chong K; Elashoff D; Wang HJ; Elashoff RM; Hoon DS
J Clin Oncol; 2012 Nov; 30(31):3819-26. PubMed ID: 23008288
[TBL] [Abstract][Full Text] [Related]
13. Prophylactic hyperthermic limb perfusion in stage I melanoma.
Krige JE; King HS; Strover RM
Eur J Surg Oncol; 1988 Aug; 14(4):321-6. PubMed ID: 3044834
[TBL] [Abstract][Full Text] [Related]
14. Hypoxic pelvic and limb perfusion with melphalan and mitomycin C for recurrent limb melanoma: a pilot study.
Guadagni S; Santinami M; Patuzzo R; Pilati PL; Miotto D; Deraco M; Rossi CR; Fiorentini G; Di Filippo F; Valenti M; Amicucci G
Melanoma Res; 2003 Feb; 13(1):51-8. PubMed ID: 12569285
[TBL] [Abstract][Full Text] [Related]
15. Repeat isolated limb perfusion with TNFalpha and melphalan for recurrent limb melanoma after failure of previous perfusion.
Noorda EM; Vrouenraets BC; Nieweg OE; van Geel AN; Eggermont AM; Kroon BB
Eur J Surg Oncol; 2006 Apr; 32(3):318-24. PubMed ID: 16412605
[TBL] [Abstract][Full Text] [Related]
16. Regional hyperthermic perfusion with melphalan after surgery for recurrent malignant melanoma of the extremities--long-term follow-up of a randomised trial.
Olofsson Bagge R; Mattsson J; Hafström L
Int J Hyperthermia; 2014 Aug; 30(5):295-8. PubMed ID: 25144818
[TBL] [Abstract][Full Text] [Related]
17. Liquid biopsy utility for the surveillance of cutaneous malignant melanoma patients.
Huang SK; Hoon DS
Mol Oncol; 2016 Mar; 10(3):450-63. PubMed ID: 26778792
[TBL] [Abstract][Full Text] [Related]
18. Circulating tumour cells in regionally metastatic cutaneous squamous cell carcinoma: A pilot study.
Morosin T; Ashford B; Ranson M; Gupta R; Clark J; Iyer NG; Spring K
Oncotarget; 2016 Jul; 7(30):47111-47115. PubMed ID: 27302928
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the liquid biopsy for the detection of BRAFV600E mutation in metastatic melanoma patients.
Salvianti F; Massi D; De Giorgi V; Gori A; Pazzagli M; Pinzani P
Cancer Biomark; 2019; 26(3):271-279. PubMed ID: 31524142
[TBL] [Abstract][Full Text] [Related]
20. Results of regional hyperthermic perfusion for primary and recurrent melanomas of the extremities.
Jönsson PE; Hafström L; Hugander A
Recent Results Cancer Res; 1983; 86():277-82. PubMed ID: 6648009
[No Abstract] [Full Text] [Related]
[Next] [New Search]